## Abstract The bioactivity of both bFGF and aFGF in the BALB/MK‐1 cell line has been compared to that of EGF. Our results indicate that, for that cell type, aFGF was far more potent than bFGF in inducing cell proliferation. In the presence of heparin, aFGF was as potent as EGF. In addition, excess
Modulation of the mitogenic response of an epidermal growth factor-dependent keratinocyte cell line by dexamethasone, insulin, and transforming growth factor-β
✍ Scribed by Joseph G. Zendegui; Wendelyn H. Inman; Graham Carpenter
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 818 KB
- Volume
- 136
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
✦ Synopsis
The stimulation of DNA synthesis by epidermal growth factor (EGF) has been studied for a cell line having properties useful for investigating the mechanism of action of EGF in epithelial cell populations. These studies employ a mouse keratinocyte cell line (MK), isolated by Weissman and Aaronson (1 983), which is stringently dependent on exogenous EGF for growth in serum containing rnedium. The studies reported here characterize the compliment of EGF receptors present on the surface of MK cells and demonstrate the regulatory influence of other hormones on the capacity of EGF to stimulate DNA synthesis. Up-regulated MK cells contain approximately 22,000 EGF receptors per cell, but when the cells are grown in the presence of EGF the receptor number is reduced to about 4,000. It is estimated that only a small number of high-affinity receptors (less than 500) are required for EGF-dependent cell proliferation. In contrast to its action in fibroblastic cells, dexamethasone is a strong inhibitor of EGF-stimulated DNA synthesis of MK cells. Insulin at high concentrations, or insulin-like growth factors I or I1 (IGF-I, IGF-II) at physiological concentrations, synergistically enhance the EGF response. Interestingly, insulin or IGF-I or II are also able to reverse most of the dexamethasone inhibition of DNA synthesis. Transforming growth factor-p (TGF-P) inhibits, in reversible manner, the EGF stimulation of DNA synthesis and this inhibition is not overcome by insulin. TCF-P receptors have been measured in M K cells and Scatchard analysis indicates approximately 20,000 receptors per cell, None of the modulatory hormones (insulin, dexamethasone, TGF-P) significantly altered '251-EGF binding characteristics in MK cells, suggesting a point of action distal to 12' 1-EGF binding
📜 SIMILAR VOLUMES
## Abstract A nonmalignant near‐diploid cell line m5s/1M, established by Sasaki and Kodama (J. Cell. Res., 131:114–122, 1987), was shown to respond to the epidermal growth factor (EGF). The m5s/1M cells showed high sensitivity to post‐confluence inhibition of cell division and formed a uniform mono
## Background: The role of growth factors in prostate cell growth has been investigated as these peptides may be involved in the autonomous growth of hormone-independent prostate cancer. ## Methods: Responses of neoplastic (pc-3 and cpa) and non-neoplastic (cape) prostatic cell lines to epidermal
## Abstract Growth factor receptors of the tyrosine kinase family regulate proliferation of a variety of cell types. In some human cancers, the epidermal growth factor receptor (EGFR) and its ligands often are overexpressed, leading to both constitutive and autocrine activation. Intracellular signa
## Abstract An immortalized clonal cell line (AP‐16) has been established from glial cultures obtained from neonatal mouse cerebra by multipassages under serum‐free conditions. Immunofluorescent experiments showed that AP‐16 cells expressed a marker for glial progenitors (A2B5) and did not express
Lovastatin (LOV), a hydroxy-methylglutaryl-coenzyme A (HMGCoA) reductase competitive inhibitor, blocks epidermal growth factor (EGF)or prostaglandin F , , (PGF,,)-induced mitogenesis in confluent resting Swiss 3T3 cells. This inhibition occurs even in the presence of insulin, which potentiates the a